前列腺特异性抗原参数与前列腺健康指数提升经会阴靶向前列腺穿刺活检对前列腺癌的预测
本研究纳入112例12针标准穿刺阴性后接受3-T多参数MRI及MRI引导经直肠靶向穿刺(MRGB)的男性,评估PSA参数与PHI联合MRGB对前列腺癌的预测价值。结果显示MRGB总体前列腺癌检出率为55%,PHI与PHID为最强预测因子,AUC分别为0.79和0.77。
要点
- 标准12针穿刺阴性后,PI-RADS 3-5病灶行MRGB的前列腺癌检出率为55%。
- PHI与PHID是前列腺癌最强预测因子,AUC分别为0.79和0.77。
- 以PHI阈值59和PHID阈值0.79可分别避免82%和62%的不必要穿刺。
核心结论
- 标准前列腺穿刺阴性后,对PI-RADS 3-5病灶行MRGB的总体前列腺癌检出率为55%。
- 结合PHI和PHID,分别有82%和62%的不必要穿刺可被避免,但分别漏诊31%和16%的前列腺癌。
研究设计与样本
- 单中心研究纳入112例男性(2014-2016年),均接受3-T多参数MRI及后续PI-RADS 3-5病灶的MRGB。
- 记录辅助PSA参数(%fPSA和PSAD)、PHI及PHI密度(PHID),并结合MRGB计算前列腺癌预测。
主要发现
- 最常见活检病灶为PI-RADS 4(66%),位于外周带(64%)、前列腺中部(58%)及前部(65%),大小为13 mm(IQR 10-15)。
- 62例(55%)患者发现前列腺癌,其中28%为Gleason评分≥7。
- 前列腺癌组与非前列腺癌组相比:PSAD 0.15 vs 0.21(P = .0051)、%fPSA 16 vs 13(P = .0191)、PHI 45 vs 69(P < .0001)、PHID 0.7 vs 1.5(P < .0001)、前列腺体积56 mL vs 45 mL(P = .0073),差异均有统计学意义。
- PHI和PHID为最强预测因子,AUC分别为0.79和0.77。
- 以最佳阈值59和0.79,PHI和PHID对前列腺癌的敏感性分别为69%和84%,特异性分别为82%和62%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess prostate cancer (PCa) detection and prediction by combining the in-bore magnetic resonance imaging-guided transrectal targeted prostate biopsy (MRGB) with prostate-specific antigen (PSA) parameters and the Prostate Health Index (PHI) in case of negative 12-core standard biopsy. MATERIALS AND METHODS: A total of 112 men (2014-2016) underwent 3-T multiparametric magnetic resonance imaging and subsequent MRGB of Prostate Imaging-Reporting and Data System (PI-RADS) lesions 3-5. Ancillary PSA parameters (PSA ratio [%fPSA] and PSA density [PSAD]) and the PHI and PHI density (PHID) were recorded. With these parameters in combination with MRGB, PCa prediction was calculated. RESULTS: The most common lesions biopsied were PI-RADS 4 (66%), located in the peripheral zone (64%), in the middle (58%) and anterior (65%) sections of the prostate, and 13 mm (IQR 10-15) in size. PCa was found in 62 (55%) patients (28% Gleason score ≥7). PSAD (0.15 vs 0.21; P = .0051), %fPSA (16 vs 13; P = .0191), PHI (45 vs 69; P < .0001), PHID (0.7 vs 1.5; P < .0001), and prostate volume (56 mL vs 45 mL; P = .0073) were significantly different in patients with PCa and those without PCa. PHI and PHID were the strongest predictors of PCa with areas under the curve of 0.79 and 0.77, respectively. Using optimal thresholds of 59 and 0.79, PHI and PHID were 69% and 84% sensitive and 82% and62% specific for PCa, respectively. CONCLUSION: Following negative standard biopsy of the prostate, the MRGB achieved an overall PCa detection rate of 55% in patients with PI-RADS 3-5 lesions. By considering PHI and PHID, 82% and 62% of unnecessary biopsies could have been avoided, failing to detect 31% and 16% of cancers.
引用
- Friedl A, Stangl K, Bauer W, et al. Prostate-specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction With the In-bore 3-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy After Negative 12-Core Biopsy. Urology. 2017. PMID: 28844600. doi:10.1016/j.urology.2017.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。